(As prepared for delivery)
With today’s consideration of H.R. 2113, the STAR Act, we will take a first, bipartisan step to address the issue of high drug prices.
WASHINGTON, DC – House Democratic leaders today unveiled a sweeping bill that would protect people living with pre-existing conditions, lower health care costs for consumers, and reverse the Trump Administration’s harmful actions to sabotage the Affordable Care Act (ACA).
This hearing continues our inquiry into pharmaceutical pricing, which our full Committee began last month. I was encouraged at that hearing that a number of our colleagues from both parties reflected on the medication problems about which their own constituents have been expressing concern.
House Ways and Means Health Subcommittee Chairman Lloyd Doggett announced today that the Subcommittee will hold a hearing, entitled “Promoting Competition to Lower Medicare Drug Prices” on Thursday, March 7, 2019, at 10:00 a.m. in room 1100 Longworth House Office Building.